Quanterix, a Cambridge, MA-based developer of single-molecule analysis technology for use in cancer and other disease diagnostics, said today that it has named David Okrongly its new CEO. Nicholas Naclerio, founding CEO of the startup, will continue to serve as its chairman. Okrongly was most recently a senior vice president in the molecular diagnostics unit of Siemens. Luke recently caught up with Quanterix scientific founder David Walt about the Tufts University chemistry professor’s success in creating value for life sciences investors, among other topics.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
